Observational study evaluating long-term safety of real-world treatment with damoctocog alfa pegol in previously treated patients with hemophilia A (HA-SAFE)

18/06/2020
02/01/2025
EU PAS number:
EUPAS33520
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

20904_Study_Protocol_Redacted_V1.0_2020-01-13

English (1.13 MB - PDF) View document
Study results
Study report
Study report

20904 Study Report Year 3_for publication.pdf

English (541.04 KB - PDF) View document

20904-study-report_year 2_for publication-updated.pdf

English (480.72 KB - PDF) View document
Other information